Mechanisms of microglia-specific genetic variants associated with Alzheimer's disease

Description of the granted funding

Alzheimer's disease (AD), the main cause of dementia world-wide, is clinically manifested as memory impairment and executive dysfunction. Most of the pathomechanistic studies in AD have so far largely concentrated on neurons, neglecting the role of other brain cells in neurodegeneration. The goal of the MgAlz project is to elucidate microglial molecular mechanisms and regulatory pathways in AD by focusing on specific AD-associated genetic variants in PLCG2 and TREM2 genes and utilizing the latest research methodologies, mouse and human-based model systems and cohorts, PET imaging, multilevel omics, endophenotype analyses, and integrative bioinformatics to advance understanding of the role of microglia in AD. This new knowledge will advance identification of novel disease mechanisms and targets to be tested as personalized medicine-based biomarkers and therapeutic targets for AD.
Show more

Starting year

2021

End year

2025

Granted funding

Mikko Hiltunen Orcid -palvelun logo
492 587 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

338182

Fields of science

Neurosciences

Research fields

Molekyyli- ja solutason neurotiede

Identified topics

brain, neuroscience